by dschulz May 4, 2022 in Lectenz® Bio News 0 0 Lectenz Bio was excited to have CEO Lori Yang and VP of R&D Sean Wu present at the Common Fund GlycoScience Program! Related Posts Lectenz Bio completes NIH I-Corps programLectenz Bio completed the Spring 2019 SBIR NIH I-Corps cohort in Bethesda Maryland! During the… Lectenz Bio accepted to NIH I-Corps programLectenz Bio has been accepted to the National Institute of Health (NIH) I-Corps program for… Lectenz Bio participates in NIH Commercialization Accelerator ProgramThe Lectenz Bio participated in the 2015-2016 Advanced Commercialization Track in the NIH Commercialization Accelerator… Related Posts GlycoSense Paper Published in Scientific Reports Dr. Sean Wu, Vice President of R&D